Search

Honglue Shen Phones & Addresses

  • Newark, DE
  • Brooklyn, NY
  • 2616 Alder Ridge Ln, Raleigh, NC 27603
  • 3111 Hillsborough St, Raleigh, NC 27607
  • Fort Collins, CO

Resumes

Resumes

Honglue Shen Photo 1

Associate Director, Immunogenicity

View page
Location:
204 Meadowdale Dr, Newark, DE 19711
Industry:
Pharmaceuticals
Work:
Teva Pharmaceuticals
Associate Director, Immunogenicity

Qps, Llc May 2014 - Mar 2016
Director In Department of Translational Medicine

Qps, Llc Apr 2011 - Apr 2014
Associate Director and Head of Immunogenicity

Qps, Llc Mar 2008 - Mar 2011
Group Leader and Head of Immunogenicity

Qps, Llc Sep 2005 - Feb 2008
Research Scientist
Education:
North Carolina State University 1999 - 2001
Beijing Normal University
Bachelor of Applied Science, Bachelors, Biochemistry
Peking Union Medical College
Doctorates, Doctor of Philosophy, Pharmacology
Skills:
Bioanalysis
Biomarkers
Assay Development
Immunogenicity
Glp
Drug Metabolism
Clinical Development
Drug Discovery
Drug Development
Pharmacokinetics
Cro
Hplc
Project Management
Cell Based Assays
Method Validation
Sop
Data Management
Analytical Method Validation
Good Laboratory Practice
Cro Management
Standard Operating Procedure
Biotechnology
Languages:
English
Mandarin
Honglue Shen Photo 2

Director, Head Of Immunogenicity Assessment

View page
Location:
Newark, DE
Work:
Teva Pharmaceuticals
Director, Head of Immunogenicity Assessment

Publications

Us Patents

Prion Protein Binding Materials And Methods Of Use

View page
US Patent:
7510848, Mar 31, 2009
Filed:
Oct 13, 2004
Appl. No.:
10/962670
Inventors:
David J. Hammond - Laytonsville MD, US
Ruben G. Carbonell - Raleigh NC, US
Honglue Shen - Raleigh NC, US
Patrick V. Gurgel - Cary NC, US
Steven J. Burton - Cambridge, GB
Assignee:
North Carolina State University - Raleigh NC
Pathogen Removal and Diagnostic Technologies Inc. - Washington DC
International Classification:
G01N 33/53
G01N 33/68
A61K 39/00
C12N 15/00
US Classification:
435 78, 435 693, 4242041, 424184, 4242481
Abstract:
Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.

Prion-Binding Ligands And Methods Of Using Same

View page
US Patent:
20040186273, Sep 23, 2004
Filed:
Mar 1, 2004
Appl. No.:
10/791516
Inventors:
David Hammond - Cortland Manor NY, US
Vite Wiltshire - Plainfield NY, US
Ruben Carbonell - Raleigh NC, US
Honglue Shen - Raleigh NC, US
International Classification:
C07K007/08
C07K007/06
C07H021/04
US Classification:
530/325000, 530/326000, 530/327000, 530/328000, 530/329000, 536/023500
Abstract:
Disclosed are ligands that bind to regions of the prion peptide and methods of using same.

Prion Protein Binding Materials And Methods Of Use

View page
US Patent:
20050014196, Jan 20, 2005
Filed:
Apr 2, 2004
Appl. No.:
10/817117
Inventors:
Ruben Carbonell - Raleigh NC, US
Honglue Shen - Raleigh NC, US
Patrick Gurgel - Cary NC, US
David Hammond - Laytonsville MD, US
Steven Burton - Little Eversden, GB
International Classification:
G01N033/53
US Classification:
435007100
Abstract:
Prion protein binding materials and methods for using the binding materials to detect or remove a prion protein from a sample, such as a biological fluid or an environmental sample. The binding materials are capable of binding to one or more forms of prion protein including cellular prion protein (PrPc), infectious prion protein (PrPsc), recombinant prion protein (PrPr), and proteinase resistant prion protein (PrPres). Prions from various species, including humans and hamsters, are bound by the binding materials.
Honglue Shen from Newark, DE, age ~55 Get Report